The Discounted Cash Flow (DCF) valuation of Tekla Healthcare Investors (HQH) is 35.84 USD. With the latest stock price at 17.25 USD, the upside of Tekla Healthcare Investors based on DCF is 107.8%.
Based on the latest price of 17.25 USD and our DCF valuation, Tekla Healthcare Investors (HQH) is a buy. buying HQH stocks now will result in a potential gain of 107.8%.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 8.3% | 7.7% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 31.51 - 41.75 | 35.84 |
| Upside | 82.7% - 142.0% | 107.8% |